Literature DB >> 6178959

Antigenic determinants of influenza virus hemagglutinin--IX. The carbohydrate side chains from an Asian strain.

L E Brown, C W Ward, D C Jackson.   

Abstract

The heavy chain (HA1) of hemagglutinin from the Asian variant A/Japan/305/57 was examined to establish which of the four oligosaccharide units on this polypeptide could cross-react with host antigen. Cyanogen bromide and enzymic digests were fractionated and the resulting peptides screened for their ability to bind to antibodies raised against uninfected chick chorioallantoic membranes. This 324 residue HA1 polypeptide from the Asian strain A/Japan/305/57 is known to contain oligosaccharide units at asparagine residues 11, 23, 285 and at either 164, 165 or both. The peptides carrying the four carbohydrate units have been isolated, the monosaccharide compositions determined and the location of the fourth oligosaccharide shown to be Asn164 by direct amino acid sequence analysis. All four sugar units on A/Japan/305/57 HA1 are of the N-acetyllactosamine type, but only the one attached to Asn11 could cross-react with anti-(host antigen) antibodies. This antigenic carbohydrate unit on the Asian hemagglutinin heavy chain is located in a similar region to the two antigenically active oligosaccharides located on the hemagglutinin from the Hong Kong variant A/Memphis/102/72. The study was therefore extended to include the early Hong Kong variant A/Aichi/2/68, which has the same oligosaccharide distribution as A/Memphis/102/72 but different sugar compositions for the individual oligosaccharide units Like A/Memphis/102/72, only the N-acetyllactosamine units attached at positions 8 and 22 of A/Aichi/2/68 were capable of binding to anti-(host antigen) IgG. Finally, the light chain (HA2) polypeptides from A/Bel/42 (HO), the A/Japan/305/57 (H2) and the two Hong Kong variants A/Aichi/2/68 (X-31) and A/Memphis/102/72 were also examined and found to contain carbohydrate which is antigenically related to chick embryo host antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178959     DOI: 10.1016/0161-5890(82)90347-9

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice.

Authors:  P C Reading; L S Morey; E C Crouch; E M Anders
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Enumeration of antigenic sites of influenza virus hemagglutinin.

Authors:  D C Jackson; J M Murray; D O White; W U Gerhard
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

3.  Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins.

Authors:  E M Anders; C A Hartley; D C Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Localization, synthesis, and activity of an antigenic site on influenza virus hemagglutinin.

Authors:  M Z Atassi; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

5.  Monoclonal antibodies against avian paramyxovirus-3: antigenic mapping and functional analysis of the haemagglutinin-neuraminidase protein and the characterization of nonspecific monoclonal antibodies.

Authors:  C L Anderson; P H Russell
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.

Authors:  Emma R Job; Barbara Bottazzi; Brad Gilbertson; Kathryn M Edenborough; Lorena E Brown; Alberto Mantovani; Andrew G Brooks; Patrick C Reading
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

7.  Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.

Authors:  Kevan L Hartshorn; Richard Webby; Mitchell R White; Tesfaldet Tecle; Clark Pan; Susan Boucher; Rodney J Moreland; Erika C Crouch; Ronald K Scheule
Journal:  Respir Res       Date:  2008-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.